Daniel Santiago Rincón Tabares

Mr. Daniel Santiago Rincón Tabares


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JHJuan C. Hernández-Valencia
Juan C. Hernández-Valencia
DTDaniel Santiago Rincón Tabares
Daniel Santiago Rincón Tabares
AMAlba Marín
Alba Marín
NNNelson Naranjo-Díaz
Nelson Naranjo-Díaz
MCMargarita María Correa
Margarita María Correa
Landscape structure influences the distribution and abundance of anopheline mosquitoes and has an indirect impact on malaria transmission. This work aimed to determine the effect of land cover and landscape fragmentation on anopheline mosquito abundance and diversity in an important Colombian malaria endemic area, the Bajo Cauca region. Diversity indices were calculated for Anopheles mosquitoes collected in various localities of the region. Land cover types were characterized using orthorectified aerial photographs to estimate landscape metrics. The relationship between landscape fragmentation and species diversity was evaluated by regression analysis. The correlation between species abundance and land cover types was determined using canonical correspondence analyses. Results showed a statistically significant tendency for a lower diversity of the Anopheles community in landscapes with higher patch number, patch density and effective mesh size. For most species, there was evidence of a significant relationship between species abundance and land covers modified by anthropic activities which generate forest loss. These results indicate that activities that modify the landscape structure and land cover composition generate changes that affect the spatial distribution and composition of epidemiologically-important Anopheles species, which may impact malaria distribution in a region. This information is useful to guide control interventions that promote unfavorable landscapes for malaria vector propagation.

4 October 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Santiago Rendon-MarinSantiago Rendon-Marin
Santiago Rendon-Marin
DTDaniel Santiago Rincón Tabares
Daniel Santiago Rincón Tabares
JTJorge Tabares
Jorge Tabares
NANatalia Arbeláez
Natalia Arbeláez
JFJorge Forero
Jorge Forero
Julián Ruiz-SáenzJulián Ruiz-Sáenz
Julián Ruiz-Sáenz
Background: Morbillivirus canis is the etiological agent of a highly contagious disease that affects diverse domestic and wild animals. Vaccination is considered the most suitable strategy for controlling CDV dissemination, transmission, and distemper disease. However, the emergence of new CDV strains has led to the need to update the current vaccine strategies employed to prevent CDV infection in domestic and wild animals. Currently, there is a lack of effective alternatives for wild animals. Diverse computational tools, especially peptide-based therapies, enable the development of new universal vaccines. Objective: The aim of this study was to evaluate the safety and humoral and cellular immune response of a new generation of vaccines based on CDV peptides as single-peptide mixtures or multiepitope CDV polypeptides in mice. Methods: Twenty-four BALB/c mice were subjected to a three-dose regimen for 28 days. Seroconversion was evaluated via ELISA, and cellular immune responses were evaluated via flow cytometry through activation-induced markers (AIMs). Results: Compared with the placebo, the peptide mixture and multiepitope CDV polypeptide were safe, and seroconversion was statistically significant in the multiepitope CDV polypeptide and commercial vaccine (CV) groups. The numbers of antigen-specific CD4+CD134+ and IFN-γ+ T cells, CD8+ T cells and TNF-α- and IL-6-producing cells were greater in the mice immunized with the multiepitope CDV polypeptide than in the control mice. Conclusion: This combined approach represents a potential step forward in developing new immunization candidates or enhancing current commercial vaccines to control CDV disease in domestic dogs and wild animals.

Verified
Journal Article
Open access
PDF file
MAMaria Suleny Serna Arbelaez
Maria Suleny Serna Arbelaez
VGValentina García-Cárcamo
Valentina García-Cárcamo
DTDaniel Santiago Rincón Tabares
Daniel Santiago Rincón Tabares
DGDiego Guerra
Diego Guerra
VLVanessa Loaiza-Cano
Vanessa Loaiza-Cano
Wildeman ZapataWildeman Zapata
Wildeman Zapata
HIV-1 infection is considered one of the major public health problems worldwide. Due to the limited access to antiretroviral therapy, the associated side effects, and the resistance that the virus can generate, it has become necessary to continue the development of new antiviral agents. The study aimed to identify potential antiviral agents for HIV-1 by evaluating the in vitro and in silico activity of 16 synthetic di-halogenated compounds derived from L-Tyrosine. The compounds were tested for cytotoxicity, which was determined using MTT, and a combined antiviral screening strategy (pre- and post-infection treatment) was performed against R5 and X4 strains of HIV-1. The most promising compounds were evaluated against a pseudotyped virus (HIV-GFP-VSV-G), and the effectiveness of these compounds was measured through GFP flow cytometry. Also, the antiviral effect of these compounds was evaluated in PBMCs using flow cytometry and ELISA for p24. The TODB-2M, TODC-2M, TODC-3M, and YDC-3M compounds showed low toxicity and significant inhibitory activity against HIV-1. In silico docking and molecular dynamics assays suggest that the compounds’ antiviral activity may be due to interaction with reverse transcriptase, viral protease, or envelope gp120.

25 February 2025 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
MNMaría M. Naranjo‐Covo
María M. Naranjo‐Covo
DTDaniel Santiago Rincón Tabares
Daniel Santiago Rincón Tabares
LFLizdany Flórez‐Álvarez
Lizdany Flórez‐Álvarez
JHJuan C. Hernandez
Juan C. Hernandez
Wildeman ZapataWildeman Zapata
Wildeman Zapata
Introduction: Although repeated exposure to HIV‐1 can result in infection, some individuals remain seronegative without clinical or serologic evidence of infection; these individuals are known as HIV‐1‐exposed seronegative individuals. This population has been extensively studied to understand the mechanisms associated with natural resistance to HIV infection. Two main hypotheses have been proposed to explain this resistance: some researchers associated resistance with a low activation phenotype characterized by a decrease in the activation and proliferation of immune system cells linked with infection control and decreased production of cytokines and pro‐inflammatory molecules, whereas others suggest that resistance is related to immune system activation and the expression of high levels of chemokines, pro‐inflammatory cytokines and antiviral molecules.Aims: Our study aims to review and analyze the most relevant evidence supporting the role of the activation level of the immune system during natural resistance to HIV‐1 infection.Methods: A search was conducted via the PubMed, SciELO and ScienceDirect databases. The literature search was performed in a nonsystematic manner. Articles published in the last five decades addressing immune activation mechanisms in natural resistance to HIV were reviewed.Results: A low‐activation phenotype, characterized by a high frequency of Treg cells; reduced expression of CD25, CD38, and HLA‐DR; and lower production of pro‐inflammatory cytokines in peripheral and mucosal tissues, plays a key role in reducing the number of activated cells susceptible to infection, but it minimizes chronic inflammation, facilitating viral entry and spread. In contrast, the activation phenotype is associated with high expression of markers such as CD25, CD38, and HLA‐DR, along with elevated high levels of interferon‐stimulated genes and pro‐inflammatory cytokines. This profile could promote infection control while increasing the number of virus‐susceptible cells.Conclusion: The complexity of the immune response during HIV exposure, reflected in the conflicting evidence concerning whether low or high immune activation offers protection against infection, suggests that there may be multiple pathways to HIV‐1 resistance, influenced by factors such as the type of viral exposure, the immune environment, and individual genetics. Further research is needed to determine which immune states are protective and how these responses can be modulated to prevent infection.

15 October 2021 in Biomédica
Verified
Journal Article
Open access
PDF file
WAWbeimar Aguilar-Jiménez
Wbeimar Aguilar-Jiménez
LFLizdany Flórez-Álvarez
Lizdany Flórez-Álvarez
DTDaniel Santiago Rincón Tabares
Daniel Santiago Rincón Tabares
DMDamariz Marín-Palma
Damariz Marín-Palma
ASAlexandra Sánchez-Martínez
Alexandra Sánchez-Martínez
MRMaría T. Rugeles
María T. Rugeles
Introduction: Immunological markers have been described during COVID-19 and persist after recovery. These immune markers are associated with clinical features among SARSCoV-2 infected individuals. Nevertheless, studies reporting a comprehensive analysis of the immune changes occurring during SARS-CoV-2 infection are still limited.Objective: To evaluate the production of proinflammatory cytokines, the antibody response, and the phenotype and function of NK cells and T cells in a Colombian family cluster with SARS-CoV-2 infection.Materials and methods: Proinflammatory cytokines were evaluated by RT-PCR and ELISA. The frequency, phenotype, and function of NK cells (cocultures with K562 cells) and T-cells (stimulated with spike/RdRp peptides) were assessed by flow cytometry. Anti-SARS-CoV-2 antibodies were determined using indirect immunofluorescence and plaque reduction neutralization assay.Results: During COVID-19, we observed a high proinflammatory-cytokine production and a reduced CD56bright-NK cell and cytotoxic response. Compared with healthy controls, infected individuals had a higher frequency of dysfunctional CD8+ T cells CD38+HLA-DR-. During the acute phase, CD8+ T cells stimulated with viral peptides exhibited a monofunctional response characterized by high IL-10 production. However, during recovery, we observed a bifunctional response characterized by the co-expression of CD107a and granzyme B or perforin.Conclusion: Although the proinflammatory response is a hallmark of SARS-CoV-2 infection, other phenotypic and functional alterations in NK cells and CD8+ T cells couldbe associated with the outcome of COVID-19. However, additional studies are required to understand these alterations and to guide future immunotherapy strategies.